VDRM (ViaDerma) Current Accrued Expense: $0.00 Mil (As of Jun. 2012)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is ViaDerma Current Accrued Expense?

ViaDerma VDRM Current Accrued Expense is $0.00 Mil as of Jun. 2012.

ViaDerma's Current Accrued Expense for the quarter that ended in Jun. 2012 was $0.00 Mil.

ViaDerma's quarterly Current Accrued Expense increased from Dec. 2011 ($0.00 Mil) to Mar. 2012 ($0.65 Mil) but then declined from Mar. 2012 ($0.65 Mil) to Jun. 2012 ($0.00 Mil).

ViaDerma's annual Current Accrued Expense declined from Dec. 2009 ($0.70 Mil) to Dec. 2010 ($0.00 Mil) but then stayed the same from Dec. 2010 ($0.00 Mil) to Dec. 2011 ($0.00 Mil).

ViaDerma Current Accrued Expense Historical Data

* Premium members only.

The historical data trend for ViaDerma's Current Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ViaDerma Current Accrued Expense Chart

ViaDerma Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11
Current Accrued Expense
0.00 0.41 0.70 0.00 0.00

ViaDerma Quarterly Data
Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11 Dec11 Mar12 Jun12
Current Accrued Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.40 0.54 0.00 0.65 0.00

ViaDerma Current Accrued Expense Calculation

Current Accrued Expense is the expense incurred during the accounting period, but not required to be paid until a later date. It includes compensation, interest, pensions and all other miscellaneous accruals reported by the company.

What does a Current Accrued Expense of $0.00 Mil mean?
ViaDerma (VDRM) has a Current Accrued Expense of $0.00 Mil as of Jun. 2012. Current Accrued Expense records the total amount of accrued expenses. View historical data on ViaDerma and its competitors.
Is ViaDerma's Current Accrued Expense too high?
ViaDerma's current Current Accrued Expense is $0.00 Mil.
How does ViaDerma's Current Accrued Expense compare to AOLS and RDGL?
ViaDerma's Current Accrued Expense of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Current Accrued Expense for a Drug Manufacturers company?
A good Current Accrued Expense depends on the Drug Manufacturers industry context. However, Current Accrued Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Current Accrued Expense mean?
A high Current Accrued Expense can signal that a stock is expensive relative to its fundamentals. Current Accrued Expense records the total amount of accrued expenses. View historical data on ViaDerma and its competitors. ViaDerma's current Current Accrued Expense is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ViaDerma stock overvalued right now?
ViaDerma (VDRM) has a current Current Accrued Expense of $0.00 Mil. The current Current Accrued Expense is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Current Accrued Expense calculated?
Current Accrued Expense is calculated from a company's financial statements. For ViaDerma (VDRM), the current Current Accrued Expense is $0.00 Mil as of Jun. 2012. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ViaDerma Business Description

Address 4640 Admiralty Way, Suite 500, Marina Del Rey, CA, USA, 90292
ViaDerma Inc is a specialty pharmaceutical company focused to bring new products to market through research and development. It is engaged in the business of manufacturing and sales of pharmaceuticals, and specifically topical antibiotics and pain management in the United States of America. Its sells under the brand name Vitastem. The Company also has products in development in the fields; anti-aging skin care, pain management, hair-loss, and toenail fungus.